170 related articles for article (PubMed ID: 25341726)
1. Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.
Gupta A; Espinosa V; Galusha LE; Rahimian V; Miro KL; Rivera-Medina A; Kasinathan C; Capitle E; Aguila HA; Kachlany SC
J Leukoc Biol; 2015 Mar; 97(3):439-46. PubMed ID: 25341726
[TBL] [Abstract][Full Text] [Related]
2. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
Kaur M; Kachlany SC
Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
[TBL] [Abstract][Full Text] [Related]
3. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
[TBL] [Abstract][Full Text] [Related]
4. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of LtxA (Leukotoxin), a Potent New Anti-Inflammatory Agent for the Treatment of Alopecia Areata.
Kachlany SC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):19-22. PubMed ID: 26551939
[TBL] [Abstract][Full Text] [Related]
6. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
7. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
[TBL] [Abstract][Full Text] [Related]
8.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
9. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of upstream TH2-cytokines in a mouse model of viral-induced asthma exacerbation.
Mahmutovic Persson I; Akbarshahi H; Menzel M; Brandelius A; Uller L
J Transl Med; 2016 Feb; 14():52. PubMed ID: 26879906
[TBL] [Abstract][Full Text] [Related]
11. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.
Stenderup K; Rosada C; Dam TN; Salerno E; Belinka BA; Kachlany SC
J Invest Dermatol; 2011 Oct; 131(10):2033-9. PubMed ID: 21654835
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
13. [Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease].
Jahnz-Rózyk K; Chciałowski A; Pirozyńska E; Rogalewska A
Pol Merkur Lekarski; 2000 Oct; 9(52):649-52. PubMed ID: 11144049
[TBL] [Abstract][Full Text] [Related]
14. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
15. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
16. Effect of the oral thrombin inhibitor dabigatran on allergic lung inflammation induced by repeated house dust mite administration in mice.
de Boer JD; Berkhout LC; de Stoppelaar SF; Yang J; Ottenhoff R; Meijers JC; Roelofs JJ; van't Veer C; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L768-75. PubMed ID: 26320153
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of a mouse neutrophil-dominated house dust mite allergic asthma model].
Li Y; Yuan Q; Huang G; Ye Y; Yu H; Xie X; Nian S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):687-692. PubMed ID: 32958124
[TBL] [Abstract][Full Text] [Related]
18. The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma.
Verheijden KAT; Braber S; Leusink-Muis T; Jeurink PV; Thijssen S; Kraneveld AD; Garssen J; Folkerts G; Willemsen LEM
Front Immunol; 2018; 9():2419. PubMed ID: 30405619
[No Abstract] [Full Text] [Related]
19. OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.
Burrows KE; Dumont C; Thompson CL; Catley MC; Dixon KL; Marshall D
Eur J Immunol; 2015 Apr; 45(4):1116-28. PubMed ID: 25545270
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]